Professionals observe pharmaceutical manufacturing machinery at a Delhi-NCR expo.
New Delhi: Pharmaceutical industry expos CPHI India and PMEC India are set to expand their footprint by utilizing two distinct venues within the Delhi-National Capital Region (NCR). This strategic decision comes in response to the significant and rapid growth experienced by India’s pharmaceutical sector, aiming to provide enhanced opportunities for business engagement and specialized networking for industry stakeholders.
CPHI India, a key event focusing on pharmaceutical ingredients and formulations, will cater to businesses involved in the upstream and midstream segments of the drug manufacturing value chain. Concurrently, PMEC India will dedicate its space to showcasing the latest advancements in pharmaceutical machinery, technology, and manufacturing solutions, serving the downstream and equipment-focused segments of the industry.
The dual-venue approach is expected to facilitate a more focused and efficient experience for attendees, allowing for deeper dives into specific areas of the pharmaceutical landscape. This expansion underscores the increasing dynamism and scale of India’s pharma industry, which has been attracting considerable attention from both domestic and international investors looking to capitalize on its growth trajectory.
About the Author
